Malalis, Baby Boy .
HRN: 26-14-45 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/10/2024
GENTAMICIN 40MG/ML, 2ML (AMP)
12/10/2024
12/17/2024
INTRAVENOUS
18 Mg
Every 24 Hours
Neonatal Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes